Keywords: بیماری های عظیم; JCOG; Japan Clinical Oncology Group; SCLC; small cell lung cancer; ED; extensive disease; OS; overall survival; WJOG; West Japan Oncology Group; NSCLC; non-small-cell lung cancer; EGFR; epidermal growth factor receptor; PFS; progression-free survival; TKI
مقالات ISI بیماری های عظیم (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Generation of a New Disease-specific Prognostic Score for Patients With Brain Metastases From Small-cell Lung Cancer Treated With Whole Brain Radiotherapy (BMS-Score) and Validation of Two Other Indices
Keywords: بیماری های عظیم; Cranial irradiation; Extensive disease; SCLC; Survival; WBRT;
Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937
Keywords: بیماری های عظیم; Small cell lung cancer; Extensive disease; Thoracic radiation therapy; PCI; Oligometastases;
Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancer
Keywords: بیماری های عظیم; Extensive disease; Small cell lung cancer; Chemotherapy; Belotecan; Cisplatin; Response;
Treatment of patients with small-cell lung cancer: From meta-analyses to clinical practice
Keywords: بیماری های عظیم; Chemotherapy; Extensive disease; Limited disease; Maintenance therapy; Meta-analysis; Randomized trial; Radiotherapy; Small-cell lung cancer
Radiotherapy in small-cell lung cancer: Where should it go?
Keywords: بیماری های عظیم; Small-cell lung cancer; Thoracic radiotherapy; Combined modality treatment; Prophylactic cranial irradiation; Limited disease; Extensive disease
Phase II Study of a 3-Day Schedule with Topotecan and Cisplatin in Patients with Previously Untreated Small Cell Lung Cancer and Extensive Disease
Keywords: بیماری های عظیم; Small cell lung cancer; Extensive disease; Topotecan; Cisplatin; Phase II
Phase II Trial with Carboplatin and Bendamustine in Patients with Extensive Stage Small-Cell Lung Cancer
Keywords: بیماری های عظیم; Small cell lung cancer; Chemotherapy; Extensive disease
Phase III study of cyclophosphamide, doxorubicin, and etoposide compared with carboplatin and paclitaxel in patients with extensive disease small-cell lung cancer
Keywords: بیماری های عظیم; Small-cell lung cancer; Chemotherapy; Extensive disease; Phase III study
Topotecan and etoposide as first-line therapy for extensive disease small cell lung cancer: a phase II trial of a platinum-free regimen
Keywords: بیماری های عظیم; SCLC; Extensive disease; First-line therapy; Topotecan; Etoposide; Platinum-free regimen;
Double-Cycle, High-Dose Ifosfamide, Carboplatin, and Etoposide Followed by Peripheral Blood Stem-Cell Transplantation for Small Cell Lung Cancer
Keywords: بیماری های عظیم; high-dose chemotherapy; peripheral blood stem-cell transplantation; small cell lung cancer; ABMT; autologous bone marrow transplantation; CR; complete response; ED; extensive disease; G-CSF; granulocyte colony-stimulating factor; ICE; ifosfamide-carboplat
Randomized phase II study comparing topotecan/cisplatin administration for 5 days versus 3 days in the treatment of extensive stage small cell lung cancer (SCLC)
Keywords: بیماری های عظیم; Chemotherapy; Small cell lung cancer; extensive disease; Topotecan; Cisplatin;